Hepatitis C Drug Pricing

The Louisiana Department of Health is seeking input from the public, health care professionals, pharmaceutical companies, and others on a plan to partner with a pharmaceutical manufacturer for unlimited access to Hepatitis C medication for Medicaid recipients and individuals in the correctional system through a subscription-based payment model.

Hepatitis C is a lethal and contagious infection causing a public health crisis in Louisiana. About 30,000 people in Louisiana's Medicaid program and prison system are carrying Hepatitis C. Nationally, Hepatitis C is the infectious disease that kills the most people annually, and rates of new infections are growing dramatically as a result of the opioid epidemic.

The state cannot afford to treat large numbers of patients at current drugs prices. Because of the high cost of the drug, only 384 people were treated in Medicaid last year. Therefore, the Department is pursuing innovative payment models which will enable the state to dramatically expand access to the drug and eventually eliminate Hepatitis C as a public health problem.

The Louisiana Department of Health is seeking public input on the creation of a subscription-based payment model for Hepatitis C medication. Under this payment model, the state would pay a drug manufacturer or manufacturers for unlimited access to the treatment for the individuals in Louisiana who are enrolled in Medicaid or in Louisiana’s correctional system. The payment to the manufacturer would be equal to or less than what the state is currently spending to provide the antiviral medication to these populations.



Whenever possible, respondents are asked to draw their responses from objective, empirical, and actionable evidence and to cite this evidence within their responses. Please provide the name, organization, address, contact number, and email address of the commenter. To be assured consideration, comments must be received by 11:59pm CST on August 24, 2018.

Click here to download the complete Request for Information for Subscription Payment Models.

Click this link to complete the form with your comments.

For further information contact Pete Croughan at pete.croughan@la.gov with “HCV RFI” in the subject line.